Reply to "The immunology of switching biologics in severe eosinophilic asthma patients''

被引：0
|
作者：
Eger, Katrien [1 ]
Pet, Lodewijk [1 ]
Weersink, J. M. [1 ]
Bel, Elisabeth H. [1 ]
机构：
[1] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Resp Med, F5-260 Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 09期
关键词：
D O I：
10.1016/j.jaip.2021.06.029
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3529 / 3529
页数：1
相关论文
共 50 条
  • [1] The immunology of switching biologics in severe eosinophilic asthma patients
    Spadaro, Giuseppe
    Lagnese, Gianluca
    Punziano, Alessandra
    Poto, Remo
    Varricchi, Gilda
    Detoraki, Aikaterini
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09): : 3528 - 3529
  • [2] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [3] BIOLOGICS SWITCH IN SEVERE EOSINOPHILIC ASTHMA
    Caminati, Marco
    Guarnieri, Gabriella
    Bagnasco, Diego
    Bianchi, Fulvia Chieco
    Carpagnano, Elisiana
    Maule, Matteo
    Molena, Beatrice
    Pelaia, Girolamo
    Pini, Laura
    Senna, Gianenrico
    Vianello, Andrea
    Crisafulli, Ernesto
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [4] Role of biologics in severe eosinophilic asthma - focus on reslizumab
    Pelaia, Girolamo
    Vatrella, Alessandro
    Busceti, Maria Teresa
    Gallelli, Luca
    Preiano, Mariaimmacolata
    Lombardo, Nicola
    Terracciano, Rosa
    Maselli, Rosario
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1075 - 1082
  • [5] Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Cetin, Gulden Pacaci
    Arslan, Bahar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1935 - 1936
  • [6] Frequency and reasons for biologics switching in severe asthma
    Gerstlauer, M.
    Seefeldt, M.
    Buhl, R.
    Hamelmann, E.
    Taube, C.
    Idzko, M.
    Korn, S.
    PNEUMOLOGIE, 2022, 76 : S31 - S31
  • [7] Advancing Care in Severe Asthma: The Art of Switching Biologics
    Dragonieri, Silvano
    Portacci, Andrea
    Quaranta, Vitaliano Nicola
    Carpagnano, Giovanna Elisiana
    ADVANCES IN RESPIRATORY MEDICINE, 2024, 92 (02) : 110 - 122
  • [8] Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
    Gomez-Bastero Fernandez, Ana
    Medina Gallardo, Juan Francisco
    Delgado Romero, Julio
    Romero Falcon, Auxiliadora
    Benito Bernaldez, Cristina
    Gallego Borrego, Javier
    Javier Alvarez-Gutierrez, Francisco
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 727 - 735
  • [9] Effectiveness of switching to Dupilumab from other biologics therapy in patients with severe asthma.
    Ais-Daza, Aureliano
    Carmona-Gonzalez, Angel
    Gutierrez-Hernandez, Sofia
    De Andres-David, Raquel
    Perez-Grimaldi, Francisco
    Soto-Campos, Gregorio
    Garcia-Morales, Sergio
    Munoz, Aurelio V. Arnedillo
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [10] SWITCHING BIOLOGICS FOR ASTHMA
    Lopez, M.
    White, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S51 - S51
12345